Galectin-4 in normal tissues and cancer

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Galectin-4 is a member of the galectin family, characterized by two distinct carbohydrate-recognition domains within a single peptide chain.
• While both domains bind lactose, they exhibit different preferences for other saccharides, enabling galectin-4 to function as a modified cross-linker.
• Galectin-4 is typically expressed in the alimentary tract and associated with cellular structures like adherens junctions and lipid rafts.

Purpose of the Study:

• To investigate the structure-function relationship of galectin-4.
• To explore the expression patterns of galectin-4 in normal tissues and cancers.
• To evaluate the potential of galectin-4 as a diagnostic marker and therapeutic target.

Main Methods:

• Bioinformatic analysis of galectin-4 domains.
• Expression analysis in various human tissues and cancer cell lines.
• Cellular localization studies and functional assays in cultured cells.

Main Results:

• Galectin-4 exhibits unique ligand-binding properties due to its two differentially specific domains.
• Expression is restricted to the alimentary tract in normal tissues but significantly induced in breast and liver cancers.
• Overexpression in vitro correlates with cellular differentiation, and intracellular galectin-4 confers resistance to nutrient starvation, while extracellular galectin-4 mediates cell adhesion.

Conclusions:

• Galectin-4's dual-domain structure provides unique cross-linking capabilities.
• Its specific expression patterns in cancer suggest potential as a diagnostic biomarker.
• Galectin-4 represents a potential target for carbohydrate-based anti-cancer drug development.